Viking Therapeutics
VKTX
VKTX
420 hedge funds and large institutions have $5.17B invested in Viking Therapeutics in 2024 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 177 increasing their positions, 101 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
420
Holders Change
+34
Holders Change %
+8.81%
% of All Funds
6.08%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
94
Increased
177
Reduced
101
Closed
58
Calls
$464M
Puts
$242M
Net Calls
+$222M
Net Calls Change
-$14.8M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$93.2M |
| 2 |
PA
Perceptive Advisors
New York
|
$108M |
| 3 |
Morgan Stanley
New York
|
$119M |
| 4 |
PL
Perpetual Ltd
Sydney, New South Wales,
Australia
|
$80.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
$29.1M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
$9.92M |
| 2 |
BlackRock
New York
|
$341M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
$45.7M |
| 4 |
Millennium Management
New York
|
$10.9M |
| 5 |
State Street
Boston,
Massachusetts
|
$296M |
